EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Scorecard

How does a completed scorecard change the decision?

Dose Diligence research deskSection 09 · Page 12 of 15Last updated 17 Nov 2026

A lower medicine price can lose without being dismissed; an unresolved gate cannot win at any price. This is a separate hypothetical scoring exercise, not an assessment of actual suppliers.

CriterionWeightCandidate A: final scoreA pointsCandidate B: final scoreB points
Fulfilment and capacity20416.0416.0
Continuity1539.0412.0
Total cost and affordability20520.0416.0
State/cohort readiness1048.048.0
Workflow and reporting1237.249.6
Patient service846.446.4
Contract and exposure1036.048.0
Implementation533.044.0
Total10075.680.0

Assume both candidates pass the gates and the ratings satisfy their evidence ceilings. Candidate A merits negotiation or a bounded pilot; Candidate B reaches final award review. A third, cheaper candidate with unresolved route eligibility remains HOLD—unranked.

Because the gap is only 4.4 points, test sensitivity. Reducing Candidate B’s fulfilment rating from 4 to 3 removes four points. The committee should therefore challenge the evidence supporting that rating rather than treat the displayed decimal as precision about future performance.

Explore the table row by row

A working view of the research

Fulfilment and capacity

Weight
20
Candidate A: final score
4
A points
16.0
Candidate B: final score
4
B points
16.0

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →